8L9-84868-09871
2 vaccinations
1 coded response
7 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 201 / VA
- Registered
- 2021-03-30
- Relationship
- Self
- Race
- White
- Ethnicity
- N/A
Timeline
-
2021-03-30
Registered in v-safe
-
2021-03-30
Dose 1 — Pfizer-BioNTech
- 2021-03-30
- 2021-04-01
- 2021-04-03
- 2021-04-04
-
2021-04-20
Dose 2 — Pfizer-BioNTech
-
2021-04-25
Survey response — days 1–6 daily, dose 2MedDRA: Body temperature increased, Fatigue, Headache, Somnolence — Feeling: GoodFree text: The 2 days following my vaccine I had elevated temp, grogginess, headache, and fatigue.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-26
- 2021-07-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-30 | Pfizer-BioNTech | |
| 2 | 2021-04-20 | Pfizer-BioNTech |
Free text
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): The 2 days following my vaccine I had elevated temp, grogginess, headache, and fatigue.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Body temperature increased | ✓ | ✓ | ✓ |
| SRO | Fatigue | ✓ | ✓ | ✓ |
| SRO | Headache | ✓ | ✓ | ✓ |
| SRO | Somnolence | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release